- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
BIO-key Previews 2017 Results Including Revenue Increasing 110 Percent to $6.3 Million
BIO-Key International (NASDAQ:BKYI) has announced unaudited preliminary results for its Q4 ended December 31, 2017 and a recap of its 2017 operating achievements. As quoted in the press release: BIO-key expects to report audited results for its FY 2017 in late March, details on the exact date and time of the earnings call will be …
BIO-Key International (NASDAQ:BKYI) has announced unaudited preliminary results for its Q4 ended December 31, 2017 and a recap of its 2017 operating achievements.
As quoted in the press release:
BIO-key expects to report audited results for its FY 2017 in late March, details on the exact date and time of the earnings call will be announced in coming weeks.
BIO-key provided the following unaudited preview of its Q4 and full year 2017 results.
Q4’17 Q4’16 Chg. 2017 2016 Chg. Revenue $3.0M $1.7M +76% $6.3M $3.0M +110% Gross Profit $2.2M $1.4M +57% $3.0M $2.2M +36% Net Income (Loss) $0.5M ($0.5M) +200% ($4.2M) ($4.2M) – BIO-key’s CEO Michael DePasquale commented, “In the past year, we worked to lay the foundation for long-term revenue growth. We focused on increasing our base of customers, growing our distribution channels, and launching a new line of products to deliver BIO-key’s secure biometric technology to both enterprise and consumer customers. Our efforts resulted in solid results including net income in our fourth quarter and 110% revenue growth in 2017. We are pleased with BIO-key’s performance as it reflects the ramping demand and growing adoption of our secure biometric solutions. I am confident that we are on the right track as we pursue our goal of becoming a profitable company.”
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.